UK Markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
29.16+0.24 (+0.83%)
At close: 04:00PM EDT
30.61 +1.45 (+4.97%)
After hours: 07:35PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts5565
Avg. Estimate-0.45-0.48-1.96-2.21
Low estimate-0.53-0.53-2.11-2.46
High estimate-0.29-0.44-1.79-1.98
Year ago EPS-0.34-0.45-1.64-1.96
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts5555
Avg. Estimate400k400k1.32M1.52M
Low estimateN/AN/AN/AN/A
High estimate1.3M1.3M3.9M5M
Year ago sales640k153k4.65M1.32M
Sales growth (year/est)-37.50%161.40%-71.60%15.20%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.4-0.36-0.42-0.45
Actual EPS-0.34-0.45-0.43-0.49
Difference0.06-0.09-0.01-0.04
Surprise %15.00%-25.00%-2.40%-8.90%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.45-0.48-1.96-2.21
7 days ago-0.44-0.47-1.88-2.16
30 days ago-0.43-0.46-1.85-2.13
60 days ago-0.43-0.46-1.85-2.13
90 days ago-0.43-0.44-1.75-2
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1132
Growth estimatesCLDXIndustrySector(s)S&P 500
Current qtr.-32.40%N/AN/AN/A
Next qtr.-6.70%N/AN/AN/A
Current year-19.50%N/AN/AN/A
Next year-12.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A